Global Antiretroviral Agent Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Antiretroviral Agent market size was valued at US$ 47300 million in 2023. With growing demand in downstream market, the Antiretroviral Agent is forecast to a readjusted size of US$ 60710 million by 2030 with a CAGR of 3.6% during review period.
The research report highlights the growth potential of the global Antiretroviral Agent market. Antiretroviral Agent are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Antiretroviral Agent. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Antiretroviral Agent market.
The clinical use of antiretroviral agents involves a pathogenesis-based, combination treatment approach. Increase in the number of chronic diseases, HIV infections will lead to more medicinal development. The surge for anti-resistant medicines has been in demand. In addition as monoclonal antibodies demand increases, the growth for the antiretroviral (ARV) agents market will spike its rate, demand in personalized medicines has increased bio production, accelerating antiretroviral (ARV) demand.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Antiretroviral Agent market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Antiretroviral Agent market. It may include historical data, market segmentation by Type (e.g., Nucleoside Reverse Transcriptase Inhibitors, Protease Inhibitors), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Antiretroviral Agent market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Antiretroviral Agent market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Antiretroviral Agent industry. This include advancements in Antiretroviral Agent technology, Antiretroviral Agent new entrants, Antiretroviral Agent new investment, and other innovations that are shaping the future of Antiretroviral Agent.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Antiretroviral Agent market. It includes factors influencing customer ' purchasing decisions, preferences for Antiretroviral Agent product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Antiretroviral Agent market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Antiretroviral Agent market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Antiretroviral Agent market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Antiretroviral Agent industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Antiretroviral Agent market.
Market Segmentation:
Antiretroviral Agent market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Antiretroviral Agent market?
What factors are driving Antiretroviral Agent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antiretroviral Agent market opportunities vary by end market size?
How does Antiretroviral Agent break out type, application?
According to our LPI (LP Information) latest study, the global Antiretroviral Agent market size was valued at US$ 47300 million in 2023. With growing demand in downstream market, the Antiretroviral Agent is forecast to a readjusted size of US$ 60710 million by 2030 with a CAGR of 3.6% during review period.
The research report highlights the growth potential of the global Antiretroviral Agent market. Antiretroviral Agent are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Antiretroviral Agent. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Antiretroviral Agent market.
The clinical use of antiretroviral agents involves a pathogenesis-based, combination treatment approach. Increase in the number of chronic diseases, HIV infections will lead to more medicinal development. The surge for anti-resistant medicines has been in demand. In addition as monoclonal antibodies demand increases, the growth for the antiretroviral (ARV) agents market will spike its rate, demand in personalized medicines has increased bio production, accelerating antiretroviral (ARV) demand.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Antiretroviral Agent market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Antiretroviral Agent market. It may include historical data, market segmentation by Type (e.g., Nucleoside Reverse Transcriptase Inhibitors, Protease Inhibitors), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Antiretroviral Agent market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Antiretroviral Agent market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Antiretroviral Agent industry. This include advancements in Antiretroviral Agent technology, Antiretroviral Agent new entrants, Antiretroviral Agent new investment, and other innovations that are shaping the future of Antiretroviral Agent.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Antiretroviral Agent market. It includes factors influencing customer ' purchasing decisions, preferences for Antiretroviral Agent product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Antiretroviral Agent market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Antiretroviral Agent market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Antiretroviral Agent market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Antiretroviral Agent industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Antiretroviral Agent market.
Market Segmentation:
Antiretroviral Agent market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Nucleoside Reverse Transcriptase Inhibitors
- Protease Inhibitors
- HIV Integrase Strand Transfer Inhibitors
- Non-Nucleoside Reverse Transcriptase Inhibitors
- Entry Inhibitors—CCR5 Co-Receptor Antagonist
- Fusion Inhibitors
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- ViiV Healthcare
- Gilead Sciences
- GlaxoSmithKline
- Merck Sharp and Dohme
- Bristol-Myers Squibb
- Janssen Pharmaceuticals
- Pfizer
- Boehringer Ingelheim
- AbbVie
- Genentech
- Mylan
What is the 10-year outlook for the global Antiretroviral Agent market?
What factors are driving Antiretroviral Agent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antiretroviral Agent market opportunities vary by end market size?
How does Antiretroviral Agent break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antiretroviral Agent Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Antiretroviral Agent by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Antiretroviral Agent by Country/Region, 2019, 2023 & 2030
2.2 Antiretroviral Agent Segment by Type
2.2.1 Nucleoside Reverse Transcriptase Inhibitors
2.2.2 Protease Inhibitors
2.2.3 HIV Integrase Strand Transfer Inhibitors
2.2.4 Non-Nucleoside Reverse Transcriptase Inhibitors
2.2.5 Entry Inhibitors—CCR5 Co-Receptor Antagonist
2.2.6 Fusion Inhibitors
2.2.7 Others
2.3 Antiretroviral Agent Sales by Type
2.3.1 Global Antiretroviral Agent Sales Market Share by Type (2019-2024)
2.3.2 Global Antiretroviral Agent Revenue and Market Share by Type (2019-2024)
2.3.3 Global Antiretroviral Agent Sale Price by Type (2019-2024)
2.4 Antiretroviral Agent Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.4.4 Others
2.5 Antiretroviral Agent Sales by Application
2.5.1 Global Antiretroviral Agent Sale Market Share by Application (2019-2024)
2.5.2 Global Antiretroviral Agent Revenue and Market Share by Application (2019-2024)
2.5.3 Global Antiretroviral Agent Sale Price by Application (2019-2024)
3 GLOBAL ANTIRETROVIRAL AGENT BY COMPANY
3.1 Global Antiretroviral Agent Breakdown Data by Company
3.1.1 Global Antiretroviral Agent Annual Sales by Company (2019-2024)
3.1.2 Global Antiretroviral Agent Sales Market Share by Company (2019-2024)
3.2 Global Antiretroviral Agent Annual Revenue by Company (2019-2024)
3.2.1 Global Antiretroviral Agent Revenue by Company (2019-2024)
3.2.2 Global Antiretroviral Agent Revenue Market Share by Company (2019-2024)
3.3 Global Antiretroviral Agent Sale Price by Company
3.4 Key Manufacturers Antiretroviral Agent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antiretroviral Agent Product Location Distribution
3.4.2 Players Antiretroviral Agent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANTIRETROVIRAL AGENT BY GEOGRAPHIC REGION
4.1 World Historic Antiretroviral Agent Market Size by Geographic Region (2019-2024)
4.1.1 Global Antiretroviral Agent Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Antiretroviral Agent Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Antiretroviral Agent Market Size by Country/Region (2019-2024)
4.2.1 Global Antiretroviral Agent Annual Sales by Country/Region (2019-2024)
4.2.2 Global Antiretroviral Agent Annual Revenue by Country/Region (2019-2024)
4.3 Americas Antiretroviral Agent Sales Growth
4.4 APAC Antiretroviral Agent Sales Growth
4.5 Europe Antiretroviral Agent Sales Growth
4.6 Middle East & Africa Antiretroviral Agent Sales Growth
5 AMERICAS
5.1 Americas Antiretroviral Agent Sales by Country
5.1.1 Americas Antiretroviral Agent Sales by Country (2019-2024)
5.1.2 Americas Antiretroviral Agent Revenue by Country (2019-2024)
5.2 Americas Antiretroviral Agent Sales by Type
5.3 Americas Antiretroviral Agent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antiretroviral Agent Sales by Region
6.1.1 APAC Antiretroviral Agent Sales by Region (2019-2024)
6.1.2 APAC Antiretroviral Agent Revenue by Region (2019-2024)
6.2 APAC Antiretroviral Agent Sales by Type
6.3 APAC Antiretroviral Agent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antiretroviral Agent by Country
7.1.1 Europe Antiretroviral Agent Sales by Country (2019-2024)
7.1.2 Europe Antiretroviral Agent Revenue by Country (2019-2024)
7.2 Europe Antiretroviral Agent Sales by Type
7.3 Europe Antiretroviral Agent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antiretroviral Agent by Country
8.1.1 Middle East & Africa Antiretroviral Agent Sales by Country (2019-2024)
8.1.2 Middle East & Africa Antiretroviral Agent Revenue by Country (2019-2024)
8.2 Middle East & Africa Antiretroviral Agent Sales by Type
8.3 Middle East & Africa Antiretroviral Agent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antiretroviral Agent
10.3 Manufacturing Process Analysis of Antiretroviral Agent
10.4 Industry Chain Structure of Antiretroviral Agent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antiretroviral Agent Distributors
11.3 Antiretroviral Agent Customer
12 WORLD FORECAST REVIEW FOR ANTIRETROVIRAL AGENT BY GEOGRAPHIC REGION
12.1 Global Antiretroviral Agent Market Size Forecast by Region
12.1.1 Global Antiretroviral Agent Forecast by Region (2025-2030)
12.1.2 Global Antiretroviral Agent Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antiretroviral Agent Forecast by Type
12.7 Global Antiretroviral Agent Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 ViiV Healthcare
13.1.1 ViiV Healthcare Company Information
13.1.2 ViiV Healthcare Antiretroviral Agent Product Portfolios and Specifications
13.1.3 ViiV Healthcare Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 ViiV Healthcare Main Business Overview
13.1.5 ViiV Healthcare Latest Developments
13.2 Gilead Sciences
13.2.1 Gilead Sciences Company Information
13.2.2 Gilead Sciences Antiretroviral Agent Product Portfolios and Specifications
13.2.3 Gilead Sciences Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Gilead Sciences Main Business Overview
13.2.5 Gilead Sciences Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Antiretroviral Agent Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 Merck Sharp and Dohme
13.4.1 Merck Sharp and Dohme Company Information
13.4.2 Merck Sharp and Dohme Antiretroviral Agent Product Portfolios and Specifications
13.4.3 Merck Sharp and Dohme Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Merck Sharp and Dohme Main Business Overview
13.4.5 Merck Sharp and Dohme Latest Developments
13.5 Bristol-Myers Squibb
13.5.1 Bristol-Myers Squibb Company Information
13.5.2 Bristol-Myers Squibb Antiretroviral Agent Product Portfolios and Specifications
13.5.3 Bristol-Myers Squibb Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Bristol-Myers Squibb Main Business Overview
13.5.5 Bristol-Myers Squibb Latest Developments
13.6 Janssen Pharmaceuticals
13.6.1 Janssen Pharmaceuticals Company Information
13.6.2 Janssen Pharmaceuticals Antiretroviral Agent Product Portfolios and Specifications
13.6.3 Janssen Pharmaceuticals Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Janssen Pharmaceuticals Main Business Overview
13.6.5 Janssen Pharmaceuticals Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Antiretroviral Agent Product Portfolios and Specifications
13.7.3 Pfizer Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Boehringer Ingelheim
13.8.1 Boehringer Ingelheim Company Information
13.8.2 Boehringer Ingelheim Antiretroviral Agent Product Portfolios and Specifications
13.8.3 Boehringer Ingelheim Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Boehringer Ingelheim Main Business Overview
13.8.5 Boehringer Ingelheim Latest Developments
13.9 AbbVie
13.9.1 AbbVie Company Information
13.9.2 AbbVie Antiretroviral Agent Product Portfolios and Specifications
13.9.3 AbbVie Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 AbbVie Main Business Overview
13.9.5 AbbVie Latest Developments
13.10 Genentech
13.10.1 Genentech Company Information
13.10.2 Genentech Antiretroviral Agent Product Portfolios and Specifications
13.10.3 Genentech Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Genentech Main Business Overview
13.10.5 Genentech Latest Developments
13.11 Mylan
13.11.1 Mylan Company Information
13.11.2 Mylan Antiretroviral Agent Product Portfolios and Specifications
13.11.3 Mylan Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Mylan Main Business Overview
13.11.5 Mylan Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antiretroviral Agent Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Antiretroviral Agent by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Antiretroviral Agent by Country/Region, 2019, 2023 & 2030
2.2 Antiretroviral Agent Segment by Type
2.2.1 Nucleoside Reverse Transcriptase Inhibitors
2.2.2 Protease Inhibitors
2.2.3 HIV Integrase Strand Transfer Inhibitors
2.2.4 Non-Nucleoside Reverse Transcriptase Inhibitors
2.2.5 Entry Inhibitors—CCR5 Co-Receptor Antagonist
2.2.6 Fusion Inhibitors
2.2.7 Others
2.3 Antiretroviral Agent Sales by Type
2.3.1 Global Antiretroviral Agent Sales Market Share by Type (2019-2024)
2.3.2 Global Antiretroviral Agent Revenue and Market Share by Type (2019-2024)
2.3.3 Global Antiretroviral Agent Sale Price by Type (2019-2024)
2.4 Antiretroviral Agent Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.4.4 Others
2.5 Antiretroviral Agent Sales by Application
2.5.1 Global Antiretroviral Agent Sale Market Share by Application (2019-2024)
2.5.2 Global Antiretroviral Agent Revenue and Market Share by Application (2019-2024)
2.5.3 Global Antiretroviral Agent Sale Price by Application (2019-2024)
3 GLOBAL ANTIRETROVIRAL AGENT BY COMPANY
3.1 Global Antiretroviral Agent Breakdown Data by Company
3.1.1 Global Antiretroviral Agent Annual Sales by Company (2019-2024)
3.1.2 Global Antiretroviral Agent Sales Market Share by Company (2019-2024)
3.2 Global Antiretroviral Agent Annual Revenue by Company (2019-2024)
3.2.1 Global Antiretroviral Agent Revenue by Company (2019-2024)
3.2.2 Global Antiretroviral Agent Revenue Market Share by Company (2019-2024)
3.3 Global Antiretroviral Agent Sale Price by Company
3.4 Key Manufacturers Antiretroviral Agent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antiretroviral Agent Product Location Distribution
3.4.2 Players Antiretroviral Agent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANTIRETROVIRAL AGENT BY GEOGRAPHIC REGION
4.1 World Historic Antiretroviral Agent Market Size by Geographic Region (2019-2024)
4.1.1 Global Antiretroviral Agent Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Antiretroviral Agent Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Antiretroviral Agent Market Size by Country/Region (2019-2024)
4.2.1 Global Antiretroviral Agent Annual Sales by Country/Region (2019-2024)
4.2.2 Global Antiretroviral Agent Annual Revenue by Country/Region (2019-2024)
4.3 Americas Antiretroviral Agent Sales Growth
4.4 APAC Antiretroviral Agent Sales Growth
4.5 Europe Antiretroviral Agent Sales Growth
4.6 Middle East & Africa Antiretroviral Agent Sales Growth
5 AMERICAS
5.1 Americas Antiretroviral Agent Sales by Country
5.1.1 Americas Antiretroviral Agent Sales by Country (2019-2024)
5.1.2 Americas Antiretroviral Agent Revenue by Country (2019-2024)
5.2 Americas Antiretroviral Agent Sales by Type
5.3 Americas Antiretroviral Agent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antiretroviral Agent Sales by Region
6.1.1 APAC Antiretroviral Agent Sales by Region (2019-2024)
6.1.2 APAC Antiretroviral Agent Revenue by Region (2019-2024)
6.2 APAC Antiretroviral Agent Sales by Type
6.3 APAC Antiretroviral Agent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antiretroviral Agent by Country
7.1.1 Europe Antiretroviral Agent Sales by Country (2019-2024)
7.1.2 Europe Antiretroviral Agent Revenue by Country (2019-2024)
7.2 Europe Antiretroviral Agent Sales by Type
7.3 Europe Antiretroviral Agent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antiretroviral Agent by Country
8.1.1 Middle East & Africa Antiretroviral Agent Sales by Country (2019-2024)
8.1.2 Middle East & Africa Antiretroviral Agent Revenue by Country (2019-2024)
8.2 Middle East & Africa Antiretroviral Agent Sales by Type
8.3 Middle East & Africa Antiretroviral Agent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antiretroviral Agent
10.3 Manufacturing Process Analysis of Antiretroviral Agent
10.4 Industry Chain Structure of Antiretroviral Agent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antiretroviral Agent Distributors
11.3 Antiretroviral Agent Customer
12 WORLD FORECAST REVIEW FOR ANTIRETROVIRAL AGENT BY GEOGRAPHIC REGION
12.1 Global Antiretroviral Agent Market Size Forecast by Region
12.1.1 Global Antiretroviral Agent Forecast by Region (2025-2030)
12.1.2 Global Antiretroviral Agent Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antiretroviral Agent Forecast by Type
12.7 Global Antiretroviral Agent Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 ViiV Healthcare
13.1.1 ViiV Healthcare Company Information
13.1.2 ViiV Healthcare Antiretroviral Agent Product Portfolios and Specifications
13.1.3 ViiV Healthcare Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 ViiV Healthcare Main Business Overview
13.1.5 ViiV Healthcare Latest Developments
13.2 Gilead Sciences
13.2.1 Gilead Sciences Company Information
13.2.2 Gilead Sciences Antiretroviral Agent Product Portfolios and Specifications
13.2.3 Gilead Sciences Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Gilead Sciences Main Business Overview
13.2.5 Gilead Sciences Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Antiretroviral Agent Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 Merck Sharp and Dohme
13.4.1 Merck Sharp and Dohme Company Information
13.4.2 Merck Sharp and Dohme Antiretroviral Agent Product Portfolios and Specifications
13.4.3 Merck Sharp and Dohme Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Merck Sharp and Dohme Main Business Overview
13.4.5 Merck Sharp and Dohme Latest Developments
13.5 Bristol-Myers Squibb
13.5.1 Bristol-Myers Squibb Company Information
13.5.2 Bristol-Myers Squibb Antiretroviral Agent Product Portfolios and Specifications
13.5.3 Bristol-Myers Squibb Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Bristol-Myers Squibb Main Business Overview
13.5.5 Bristol-Myers Squibb Latest Developments
13.6 Janssen Pharmaceuticals
13.6.1 Janssen Pharmaceuticals Company Information
13.6.2 Janssen Pharmaceuticals Antiretroviral Agent Product Portfolios and Specifications
13.6.3 Janssen Pharmaceuticals Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Janssen Pharmaceuticals Main Business Overview
13.6.5 Janssen Pharmaceuticals Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Antiretroviral Agent Product Portfolios and Specifications
13.7.3 Pfizer Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Boehringer Ingelheim
13.8.1 Boehringer Ingelheim Company Information
13.8.2 Boehringer Ingelheim Antiretroviral Agent Product Portfolios and Specifications
13.8.3 Boehringer Ingelheim Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Boehringer Ingelheim Main Business Overview
13.8.5 Boehringer Ingelheim Latest Developments
13.9 AbbVie
13.9.1 AbbVie Company Information
13.9.2 AbbVie Antiretroviral Agent Product Portfolios and Specifications
13.9.3 AbbVie Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 AbbVie Main Business Overview
13.9.5 AbbVie Latest Developments
13.10 Genentech
13.10.1 Genentech Company Information
13.10.2 Genentech Antiretroviral Agent Product Portfolios and Specifications
13.10.3 Genentech Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Genentech Main Business Overview
13.10.5 Genentech Latest Developments
13.11 Mylan
13.11.1 Mylan Company Information
13.11.2 Mylan Antiretroviral Agent Product Portfolios and Specifications
13.11.3 Mylan Antiretroviral Agent Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Mylan Main Business Overview
13.11.5 Mylan Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Antiretroviral Agent Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Antiretroviral Agent Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Nucleoside Reverse Transcriptase Inhibitors
Table 4. Major Players of Protease Inhibitors
Table 5. Major Players of HIV Integrase Strand Transfer Inhibitors
Table 6. Major Players of Non-Nucleoside Reverse Transcriptase Inhibitors
Table 7. Major Players of Entry Inhibitors—CCR5 Co-Receptor Antagonist
Table 8. Major Players of Fusion Inhibitors
Table 9. Major Players of Others
Table 10. Global Antiretroviral Agent Sales by Type (2019-2024) & (K Units)
Table 11. Global Antiretroviral Agent Sales Market Share by Type (2019-2024)
Table 12. Global Antiretroviral Agent Revenue by Type (2019-2024) & ($ million)
Table 13. Global Antiretroviral Agent Revenue Market Share by Type (2019-2024)
Table 14. Global Antiretroviral Agent Sale Price by Type (2019-2024) & (US$/Unit)
Table 15. Global Antiretroviral Agent Sales by Application (2019-2024) & (K Units)
Table 16. Global Antiretroviral Agent Sales Market Share by Application (2019-2024)
Table 17. Global Antiretroviral Agent Revenue by Application (2019-2024)
Table 18. Global Antiretroviral Agent Revenue Market Share by Application (2019-2024)
Table 19. Global Antiretroviral Agent Sale Price by Application (2019-2024) & (US$/Unit)
Table 20. Global Antiretroviral Agent Sales by Company (2019-2024) & (K Units)
Table 21. Global Antiretroviral Agent Sales Market Share by Company (2019-2024)
Table 22. Global Antiretroviral Agent Revenue by Company (2019-2024) ($ Millions)
Table 23. Global Antiretroviral Agent Revenue Market Share by Company (2019-2024)
Table 24. Global Antiretroviral Agent Sale Price by Company (2019-2024) & (US$/Unit)
Table 25. Key Manufacturers Antiretroviral Agent Producing Area Distribution and Sales Area
Table 26. Players Antiretroviral Agent Products Offered
Table 27. Antiretroviral Agent Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Antiretroviral Agent Sales by Geographic Region (2019-2024) & (K Units)
Table 31. Global Antiretroviral Agent Sales Market Share Geographic Region (2019-2024)
Table 32. Global Antiretroviral Agent Revenue by Geographic Region (2019-2024) & ($ millions)
Table 33. Global Antiretroviral Agent Revenue Market Share by Geographic Region (2019-2024)
Table 34. Global Antiretroviral Agent Sales by Country/Region (2019-2024) & (K Units)
Table 35. Global Antiretroviral Agent Sales Market Share by Country/Region (2019-2024)
Table 36. Global Antiretroviral Agent Revenue by Country/Region (2019-2024) & ($ millions)
Table 37. Global Antiretroviral Agent Revenue Market Share by Country/Region (2019-2024)
Table 38. Americas Antiretroviral Agent Sales by Country (2019-2024) & (K Units)
Table 39. Americas Antiretroviral Agent Sales Market Share by Country (2019-2024)
Table 40. Americas Antiretroviral Agent Revenue by Country (2019-2024) & ($ Millions)
Table 41. Americas Antiretroviral Agent Revenue Market Share by Country (2019-2024)
Table 42. Americas Antiretroviral Agent Sales by Type (2019-2024) & (K Units)
Table 43. Americas Antiretroviral Agent Sales by Application (2019-2024) & (K Units)
Table 44. APAC Antiretroviral Agent Sales by Region (2019-2024) & (K Units)
Table 45. APAC Antiretroviral Agent Sales Market Share by Region (2019-2024)
Table 46. APAC Antiretroviral Agent Revenue by Region (2019-2024) & ($ Millions)
Table 47. APAC Antiretroviral Agent Revenue Market Share by Region (2019-2024)
Table 48. APAC Antiretroviral Agent Sales by Type (2019-2024) & (K Units)
Table 49. APAC Antiretroviral Agent Sales by Application (2019-2024) & (K Units)
Table 50. Europe Antiretroviral Agent Sales by Country (2019-2024) & (K Units)
Table 51. Europe Antiretroviral Agent Sales Market Share by Country (2019-2024)
Table 52. Europe Antiretroviral Agent Revenue by Country (2019-2024) & ($ Millions)
Table 53. Europe Antiretroviral Agent Revenue Market Share by Country (2019-2024)
Table 54. Europe Antiretroviral Agent Sales by Type (2019-2024) & (K Units)
Table 55. Europe Antiretroviral Agent Sales by Application (2019-2024) & (K Units)
Table 56. Middle East & Africa Antiretroviral Agent Sales by Country (2019-2024) & (K Units)
Table 57. Middle East & Africa Antiretroviral Agent Sales Market Share by Country (2019-2024)
Table 58. Middle East & Africa Antiretroviral Agent Revenue by Country (2019-2024) & ($ Millions)
Table 59. Middle East & Africa Antiretroviral Agent Revenue Market Share by Country (2019-2024)
Table 60. Middle East & Africa Antiretroviral Agent Sales by Type (2019-2024) & (K Units)
Table 61. Middle East & Africa Antiretroviral Agent Sales by Application (2019-2024) & (K Units)
Table 62. Key Market Drivers & Growth Opportunities of Antiretroviral Agent
Table 63. Key Market Challenges & Risks of Antiretroviral Agent
Table 64. Key Industry Trends of Antiretroviral Agent
Table 65. Antiretroviral Agent Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. Antiretroviral Agent Distributors List
Table 68. Antiretroviral Agent Customer List
Table 69. Global Antiretroviral Agent Sales Forecast by Region (2025-2030) & (K Units)
Table 70. Global Antiretroviral Agent Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Americas Antiretroviral Agent Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Americas Antiretroviral Agent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. APAC Antiretroviral Agent Sales Forecast by Region (2025-2030) & (K Units)
Table 74. APAC Antiretroviral Agent Revenue Forecast by Region (2025-2030) & ($ millions)
Table 75. Europe Antiretroviral Agent Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Europe Antiretroviral Agent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Middle East & Africa Antiretroviral Agent Sales Forecast by Country (2025-2030) & (K Units)
Table 78. Middle East & Africa Antiretroviral Agent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 79. Global Antiretroviral Agent Sales Forecast by Type (2025-2030) & (K Units)
Table 80. Global Antiretroviral Agent Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 81. Global Antiretroviral Agent Sales Forecast by Application (2025-2030) & (K Units)
Table 82. Global Antiretroviral Agent Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 83. ViiV Healthcare Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 84. ViiV Healthcare Antiretroviral Agent Product Portfolios and Specifications
Table 85. ViiV Healthcare Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. ViiV Healthcare Main Business
Table 87. ViiV Healthcare Latest Developments
Table 88. Gilead Sciences Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 89. Gilead Sciences Antiretroviral Agent Product Portfolios and Specifications
Table 90. Gilead Sciences Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Gilead Sciences Main Business
Table 92. Gilead Sciences Latest Developments
Table 93. GlaxoSmithKline Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 94. GlaxoSmithKline Antiretroviral Agent Product Portfolios and Specifications
Table 95. GlaxoSmithKline Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. GlaxoSmithKline Main Business
Table 97. GlaxoSmithKline Latest Developments
Table 98. Merck Sharp and Dohme Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck Sharp and Dohme Antiretroviral Agent Product Portfolios and Specifications
Table 100. Merck Sharp and Dohme Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Merck Sharp and Dohme Main Business
Table 102. Merck Sharp and Dohme Latest Developments
Table 103. Bristol-Myers Squibb Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 104. Bristol-Myers Squibb Antiretroviral Agent Product Portfolios and Specifications
Table 105. Bristol-Myers Squibb Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Bristol-Myers Squibb Main Business
Table 107. Bristol-Myers Squibb Latest Developments
Table 108. Janssen Pharmaceuticals Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 109. Janssen Pharmaceuticals Antiretroviral Agent Product Portfolios and Specifications
Table 110. Janssen Pharmaceuticals Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Janssen Pharmaceuticals Main Business
Table 112. Janssen Pharmaceuticals Latest Developments
Table 113. Pfizer Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 114. Pfizer Antiretroviral Agent Product Portfolios and Specifications
Table 115. Pfizer Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Pfizer Main Business
Table 117. Pfizer Latest Developments
Table 118. Boehringer Ingelheim Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 119. Boehringer Ingelheim Antiretroviral Agent Product Portfolios and Specifications
Table 120. Boehringer Ingelheim Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Boehringer Ingelheim Main Business
Table 122. Boehringer Ingelheim Latest Developments
Table 123. AbbVie Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 124. AbbVie Antiretroviral Agent Product Portfolios and Specifications
Table 125. AbbVie Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. AbbVie Main Business
Table 127. AbbVie Latest Developments
Table 128. Genentech Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 129. Genentech Antiretroviral Agent Product Portfolios and Specifications
Table 130. Genentech Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. Genentech Main Business
Table 132. Genentech Latest Developments
Table 133. Mylan Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 134. Mylan Antiretroviral Agent Product Portfolios and Specifications
Table 135. Mylan Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. Mylan Main Business
Table 137. Mylan Latest Developments
Table 1. Antiretroviral Agent Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Antiretroviral Agent Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Nucleoside Reverse Transcriptase Inhibitors
Table 4. Major Players of Protease Inhibitors
Table 5. Major Players of HIV Integrase Strand Transfer Inhibitors
Table 6. Major Players of Non-Nucleoside Reverse Transcriptase Inhibitors
Table 7. Major Players of Entry Inhibitors—CCR5 Co-Receptor Antagonist
Table 8. Major Players of Fusion Inhibitors
Table 9. Major Players of Others
Table 10. Global Antiretroviral Agent Sales by Type (2019-2024) & (K Units)
Table 11. Global Antiretroviral Agent Sales Market Share by Type (2019-2024)
Table 12. Global Antiretroviral Agent Revenue by Type (2019-2024) & ($ million)
Table 13. Global Antiretroviral Agent Revenue Market Share by Type (2019-2024)
Table 14. Global Antiretroviral Agent Sale Price by Type (2019-2024) & (US$/Unit)
Table 15. Global Antiretroviral Agent Sales by Application (2019-2024) & (K Units)
Table 16. Global Antiretroviral Agent Sales Market Share by Application (2019-2024)
Table 17. Global Antiretroviral Agent Revenue by Application (2019-2024)
Table 18. Global Antiretroviral Agent Revenue Market Share by Application (2019-2024)
Table 19. Global Antiretroviral Agent Sale Price by Application (2019-2024) & (US$/Unit)
Table 20. Global Antiretroviral Agent Sales by Company (2019-2024) & (K Units)
Table 21. Global Antiretroviral Agent Sales Market Share by Company (2019-2024)
Table 22. Global Antiretroviral Agent Revenue by Company (2019-2024) ($ Millions)
Table 23. Global Antiretroviral Agent Revenue Market Share by Company (2019-2024)
Table 24. Global Antiretroviral Agent Sale Price by Company (2019-2024) & (US$/Unit)
Table 25. Key Manufacturers Antiretroviral Agent Producing Area Distribution and Sales Area
Table 26. Players Antiretroviral Agent Products Offered
Table 27. Antiretroviral Agent Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Antiretroviral Agent Sales by Geographic Region (2019-2024) & (K Units)
Table 31. Global Antiretroviral Agent Sales Market Share Geographic Region (2019-2024)
Table 32. Global Antiretroviral Agent Revenue by Geographic Region (2019-2024) & ($ millions)
Table 33. Global Antiretroviral Agent Revenue Market Share by Geographic Region (2019-2024)
Table 34. Global Antiretroviral Agent Sales by Country/Region (2019-2024) & (K Units)
Table 35. Global Antiretroviral Agent Sales Market Share by Country/Region (2019-2024)
Table 36. Global Antiretroviral Agent Revenue by Country/Region (2019-2024) & ($ millions)
Table 37. Global Antiretroviral Agent Revenue Market Share by Country/Region (2019-2024)
Table 38. Americas Antiretroviral Agent Sales by Country (2019-2024) & (K Units)
Table 39. Americas Antiretroviral Agent Sales Market Share by Country (2019-2024)
Table 40. Americas Antiretroviral Agent Revenue by Country (2019-2024) & ($ Millions)
Table 41. Americas Antiretroviral Agent Revenue Market Share by Country (2019-2024)
Table 42. Americas Antiretroviral Agent Sales by Type (2019-2024) & (K Units)
Table 43. Americas Antiretroviral Agent Sales by Application (2019-2024) & (K Units)
Table 44. APAC Antiretroviral Agent Sales by Region (2019-2024) & (K Units)
Table 45. APAC Antiretroviral Agent Sales Market Share by Region (2019-2024)
Table 46. APAC Antiretroviral Agent Revenue by Region (2019-2024) & ($ Millions)
Table 47. APAC Antiretroviral Agent Revenue Market Share by Region (2019-2024)
Table 48. APAC Antiretroviral Agent Sales by Type (2019-2024) & (K Units)
Table 49. APAC Antiretroviral Agent Sales by Application (2019-2024) & (K Units)
Table 50. Europe Antiretroviral Agent Sales by Country (2019-2024) & (K Units)
Table 51. Europe Antiretroviral Agent Sales Market Share by Country (2019-2024)
Table 52. Europe Antiretroviral Agent Revenue by Country (2019-2024) & ($ Millions)
Table 53. Europe Antiretroviral Agent Revenue Market Share by Country (2019-2024)
Table 54. Europe Antiretroviral Agent Sales by Type (2019-2024) & (K Units)
Table 55. Europe Antiretroviral Agent Sales by Application (2019-2024) & (K Units)
Table 56. Middle East & Africa Antiretroviral Agent Sales by Country (2019-2024) & (K Units)
Table 57. Middle East & Africa Antiretroviral Agent Sales Market Share by Country (2019-2024)
Table 58. Middle East & Africa Antiretroviral Agent Revenue by Country (2019-2024) & ($ Millions)
Table 59. Middle East & Africa Antiretroviral Agent Revenue Market Share by Country (2019-2024)
Table 60. Middle East & Africa Antiretroviral Agent Sales by Type (2019-2024) & (K Units)
Table 61. Middle East & Africa Antiretroviral Agent Sales by Application (2019-2024) & (K Units)
Table 62. Key Market Drivers & Growth Opportunities of Antiretroviral Agent
Table 63. Key Market Challenges & Risks of Antiretroviral Agent
Table 64. Key Industry Trends of Antiretroviral Agent
Table 65. Antiretroviral Agent Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. Antiretroviral Agent Distributors List
Table 68. Antiretroviral Agent Customer List
Table 69. Global Antiretroviral Agent Sales Forecast by Region (2025-2030) & (K Units)
Table 70. Global Antiretroviral Agent Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Americas Antiretroviral Agent Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Americas Antiretroviral Agent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. APAC Antiretroviral Agent Sales Forecast by Region (2025-2030) & (K Units)
Table 74. APAC Antiretroviral Agent Revenue Forecast by Region (2025-2030) & ($ millions)
Table 75. Europe Antiretroviral Agent Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Europe Antiretroviral Agent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Middle East & Africa Antiretroviral Agent Sales Forecast by Country (2025-2030) & (K Units)
Table 78. Middle East & Africa Antiretroviral Agent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 79. Global Antiretroviral Agent Sales Forecast by Type (2025-2030) & (K Units)
Table 80. Global Antiretroviral Agent Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 81. Global Antiretroviral Agent Sales Forecast by Application (2025-2030) & (K Units)
Table 82. Global Antiretroviral Agent Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 83. ViiV Healthcare Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 84. ViiV Healthcare Antiretroviral Agent Product Portfolios and Specifications
Table 85. ViiV Healthcare Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. ViiV Healthcare Main Business
Table 87. ViiV Healthcare Latest Developments
Table 88. Gilead Sciences Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 89. Gilead Sciences Antiretroviral Agent Product Portfolios and Specifications
Table 90. Gilead Sciences Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Gilead Sciences Main Business
Table 92. Gilead Sciences Latest Developments
Table 93. GlaxoSmithKline Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 94. GlaxoSmithKline Antiretroviral Agent Product Portfolios and Specifications
Table 95. GlaxoSmithKline Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. GlaxoSmithKline Main Business
Table 97. GlaxoSmithKline Latest Developments
Table 98. Merck Sharp and Dohme Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck Sharp and Dohme Antiretroviral Agent Product Portfolios and Specifications
Table 100. Merck Sharp and Dohme Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Merck Sharp and Dohme Main Business
Table 102. Merck Sharp and Dohme Latest Developments
Table 103. Bristol-Myers Squibb Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 104. Bristol-Myers Squibb Antiretroviral Agent Product Portfolios and Specifications
Table 105. Bristol-Myers Squibb Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Bristol-Myers Squibb Main Business
Table 107. Bristol-Myers Squibb Latest Developments
Table 108. Janssen Pharmaceuticals Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 109. Janssen Pharmaceuticals Antiretroviral Agent Product Portfolios and Specifications
Table 110. Janssen Pharmaceuticals Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Janssen Pharmaceuticals Main Business
Table 112. Janssen Pharmaceuticals Latest Developments
Table 113. Pfizer Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 114. Pfizer Antiretroviral Agent Product Portfolios and Specifications
Table 115. Pfizer Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Pfizer Main Business
Table 117. Pfizer Latest Developments
Table 118. Boehringer Ingelheim Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 119. Boehringer Ingelheim Antiretroviral Agent Product Portfolios and Specifications
Table 120. Boehringer Ingelheim Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Boehringer Ingelheim Main Business
Table 122. Boehringer Ingelheim Latest Developments
Table 123. AbbVie Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 124. AbbVie Antiretroviral Agent Product Portfolios and Specifications
Table 125. AbbVie Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. AbbVie Main Business
Table 127. AbbVie Latest Developments
Table 128. Genentech Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 129. Genentech Antiretroviral Agent Product Portfolios and Specifications
Table 130. Genentech Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. Genentech Main Business
Table 132. Genentech Latest Developments
Table 133. Mylan Basic Information, Antiretroviral Agent Manufacturing Base, Sales Area and Its Competitors
Table 134. Mylan Antiretroviral Agent Product Portfolios and Specifications
Table 135. Mylan Antiretroviral Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. Mylan Main Business
Table 137. Mylan Latest Developments
LIST OF FIGURES
Figure 1. Picture of Antiretroviral Agent
Figure 2. Antiretroviral Agent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antiretroviral Agent Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Antiretroviral Agent Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Antiretroviral Agent Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Nucleoside Reverse Transcriptase Inhibitors
Figure 10. Product Picture of Protease Inhibitors
Figure 11. Product Picture of HIV Integrase Strand Transfer Inhibitors
Figure 12. Product Picture of Non-Nucleoside Reverse Transcriptase Inhibitors
Figure 13. Product Picture of Entry Inhibitors—CCR5 Co-Receptor Antagonist
Figure 14. Product Picture of Fusion Inhibitors
Figure 15. Product Picture of Others
Figure 16. Global Antiretroviral Agent Sales Market Share by Type in 2023
Figure 17. Global Antiretroviral Agent Revenue Market Share by Type (2019-2024)
Figure 18. Antiretroviral Agent Consumed in Hospital Pharmacies
Figure 19. Global Antiretroviral Agent Market: Hospital Pharmacies (2019-2024) & (K Units)
Figure 20. Antiretroviral Agent Consumed in Retail Pharmacies
Figure 21. Global Antiretroviral Agent Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 22. Antiretroviral Agent Consumed in Online Pharmacies
Figure 23. Global Antiretroviral Agent Market: Online Pharmacies (2019-2024) & (K Units)
Figure 24. Antiretroviral Agent Consumed in Others
Figure 25. Global Antiretroviral Agent Market: Others (2019-2024) & (K Units)
Figure 26. Global Antiretroviral Agent Sales Market Share by Application (2023)
Figure 27. Global Antiretroviral Agent Revenue Market Share by Application in 2023
Figure 28. Antiretroviral Agent Sales Market by Company in 2023 (K Units)
Figure 29. Global Antiretroviral Agent Sales Market Share by Company in 2023
Figure 30. Antiretroviral Agent Revenue Market by Company in 2023 ($ Million)
Figure 31. Global Antiretroviral Agent Revenue Market Share by Company in 2023
Figure 32. Global Antiretroviral Agent Sales Market Share by Geographic Region (2019-2024)
Figure 33. Global Antiretroviral Agent Revenue Market Share by Geographic Region in 2023
Figure 34. Americas Antiretroviral Agent Sales 2019-2024 (K Units)
Figure 35. Americas Antiretroviral Agent Revenue 2019-2024 ($ Millions)
Figure 36. APAC Antiretroviral Agent Sales 2019-2024 (K Units)
Figure 37. APAC Antiretroviral Agent Revenue 2019-2024 ($ Millions)
Figure 38. Europe Antiretroviral Agent Sales 2019-2024 (K Units)
Figure 39. Europe Antiretroviral Agent Revenue 2019-2024 ($ Millions)
Figure 40. Middle East & Africa Antiretroviral Agent Sales 2019-2024 (K Units)
Figure 41. Middle East & Africa Antiretroviral Agent Revenue 2019-2024 ($ Millions)
Figure 42. Americas Antiretroviral Agent Sales Market Share by Country in 2023
Figure 43. Americas Antiretroviral Agent Revenue Market Share by Country in 2023
Figure 44. Americas Antiretroviral Agent Sales Market Share by Type (2019-2024)
Figure 45. Americas Antiretroviral Agent Sales Market Share by Application (2019-2024)
Figure 46. United States Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 47. Canada Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 48. Mexico Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 49. Brazil Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 50. APAC Antiretroviral Agent Sales Market Share by Region in 2023
Figure 51. APAC Antiretroviral Agent Revenue Market Share by Regions in 2023
Figure 52. APAC Antiretroviral Agent Sales Market Share by Type (2019-2024)
Figure 53. APAC Antiretroviral Agent Sales Market Share by Application (2019-2024)
Figure 54. China Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 55. Japan Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 56. South Korea Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 57. Southeast Asia Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 58. India Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 59. Australia Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 60. China Taiwan Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 61. Europe Antiretroviral Agent Sales Market Share by Country in 2023
Figure 62. Europe Antiretroviral Agent Revenue Market Share by Country in 2023
Figure 63. Europe Antiretroviral Agent Sales Market Share by Type (2019-2024)
Figure 64. Europe Antiretroviral Agent Sales Market Share by Application (2019-2024)
Figure 65. Germany Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 66. France Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 67. UK Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 68. Italy Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 69. Russia Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 70. Middle East & Africa Antiretroviral Agent Sales Market Share by Country in 2023
Figure 71. Middle East & Africa Antiretroviral Agent Revenue Market Share by Country in 2023
Figure 72. Middle East & Africa Antiretroviral Agent Sales Market Share by Type (2019-2024)
Figure 73. Middle East & Africa Antiretroviral Agent Sales Market Share by Application (2019-2024)
Figure 74. Egypt Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 75. South Africa Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 76. Israel Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 77. Turkey Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 78. GCC Country Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Antiretroviral Agent in 2023
Figure 80. Manufacturing Process Analysis of Antiretroviral Agent
Figure 81. Industry Chain Structure of Antiretroviral Agent
Figure 82. Channels of Distribution
Figure 83. Global Antiretroviral Agent Sales Market Forecast by Region (2025-2030)
Figure 84. Global Antiretroviral Agent Revenue Market Share Forecast by Region (2025-2030)
Figure 85. Global Antiretroviral Agent Sales Market Share Forecast by Type (2025-2030)
Figure 86. Global Antiretroviral Agent Revenue Market Share Forecast by Type (2025-2030)
Figure 87. Global Antiretroviral Agent Sales Market Share Forecast by Application (2025-2030)
Figure 88. Global Antiretroviral Agent Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Antiretroviral Agent
Figure 2. Antiretroviral Agent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antiretroviral Agent Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Antiretroviral Agent Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Antiretroviral Agent Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Nucleoside Reverse Transcriptase Inhibitors
Figure 10. Product Picture of Protease Inhibitors
Figure 11. Product Picture of HIV Integrase Strand Transfer Inhibitors
Figure 12. Product Picture of Non-Nucleoside Reverse Transcriptase Inhibitors
Figure 13. Product Picture of Entry Inhibitors—CCR5 Co-Receptor Antagonist
Figure 14. Product Picture of Fusion Inhibitors
Figure 15. Product Picture of Others
Figure 16. Global Antiretroviral Agent Sales Market Share by Type in 2023
Figure 17. Global Antiretroviral Agent Revenue Market Share by Type (2019-2024)
Figure 18. Antiretroviral Agent Consumed in Hospital Pharmacies
Figure 19. Global Antiretroviral Agent Market: Hospital Pharmacies (2019-2024) & (K Units)
Figure 20. Antiretroviral Agent Consumed in Retail Pharmacies
Figure 21. Global Antiretroviral Agent Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 22. Antiretroviral Agent Consumed in Online Pharmacies
Figure 23. Global Antiretroviral Agent Market: Online Pharmacies (2019-2024) & (K Units)
Figure 24. Antiretroviral Agent Consumed in Others
Figure 25. Global Antiretroviral Agent Market: Others (2019-2024) & (K Units)
Figure 26. Global Antiretroviral Agent Sales Market Share by Application (2023)
Figure 27. Global Antiretroviral Agent Revenue Market Share by Application in 2023
Figure 28. Antiretroviral Agent Sales Market by Company in 2023 (K Units)
Figure 29. Global Antiretroviral Agent Sales Market Share by Company in 2023
Figure 30. Antiretroviral Agent Revenue Market by Company in 2023 ($ Million)
Figure 31. Global Antiretroviral Agent Revenue Market Share by Company in 2023
Figure 32. Global Antiretroviral Agent Sales Market Share by Geographic Region (2019-2024)
Figure 33. Global Antiretroviral Agent Revenue Market Share by Geographic Region in 2023
Figure 34. Americas Antiretroviral Agent Sales 2019-2024 (K Units)
Figure 35. Americas Antiretroviral Agent Revenue 2019-2024 ($ Millions)
Figure 36. APAC Antiretroviral Agent Sales 2019-2024 (K Units)
Figure 37. APAC Antiretroviral Agent Revenue 2019-2024 ($ Millions)
Figure 38. Europe Antiretroviral Agent Sales 2019-2024 (K Units)
Figure 39. Europe Antiretroviral Agent Revenue 2019-2024 ($ Millions)
Figure 40. Middle East & Africa Antiretroviral Agent Sales 2019-2024 (K Units)
Figure 41. Middle East & Africa Antiretroviral Agent Revenue 2019-2024 ($ Millions)
Figure 42. Americas Antiretroviral Agent Sales Market Share by Country in 2023
Figure 43. Americas Antiretroviral Agent Revenue Market Share by Country in 2023
Figure 44. Americas Antiretroviral Agent Sales Market Share by Type (2019-2024)
Figure 45. Americas Antiretroviral Agent Sales Market Share by Application (2019-2024)
Figure 46. United States Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 47. Canada Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 48. Mexico Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 49. Brazil Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 50. APAC Antiretroviral Agent Sales Market Share by Region in 2023
Figure 51. APAC Antiretroviral Agent Revenue Market Share by Regions in 2023
Figure 52. APAC Antiretroviral Agent Sales Market Share by Type (2019-2024)
Figure 53. APAC Antiretroviral Agent Sales Market Share by Application (2019-2024)
Figure 54. China Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 55. Japan Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 56. South Korea Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 57. Southeast Asia Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 58. India Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 59. Australia Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 60. China Taiwan Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 61. Europe Antiretroviral Agent Sales Market Share by Country in 2023
Figure 62. Europe Antiretroviral Agent Revenue Market Share by Country in 2023
Figure 63. Europe Antiretroviral Agent Sales Market Share by Type (2019-2024)
Figure 64. Europe Antiretroviral Agent Sales Market Share by Application (2019-2024)
Figure 65. Germany Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 66. France Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 67. UK Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 68. Italy Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 69. Russia Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 70. Middle East & Africa Antiretroviral Agent Sales Market Share by Country in 2023
Figure 71. Middle East & Africa Antiretroviral Agent Revenue Market Share by Country in 2023
Figure 72. Middle East & Africa Antiretroviral Agent Sales Market Share by Type (2019-2024)
Figure 73. Middle East & Africa Antiretroviral Agent Sales Market Share by Application (2019-2024)
Figure 74. Egypt Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 75. South Africa Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 76. Israel Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 77. Turkey Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 78. GCC Country Antiretroviral Agent Revenue Growth 2019-2024 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Antiretroviral Agent in 2023
Figure 80. Manufacturing Process Analysis of Antiretroviral Agent
Figure 81. Industry Chain Structure of Antiretroviral Agent
Figure 82. Channels of Distribution
Figure 83. Global Antiretroviral Agent Sales Market Forecast by Region (2025-2030)
Figure 84. Global Antiretroviral Agent Revenue Market Share Forecast by Region (2025-2030)
Figure 85. Global Antiretroviral Agent Sales Market Share Forecast by Type (2025-2030)
Figure 86. Global Antiretroviral Agent Revenue Market Share Forecast by Type (2025-2030)
Figure 87. Global Antiretroviral Agent Sales Market Share Forecast by Application (2025-2030)
Figure 88. Global Antiretroviral Agent Revenue Market Share Forecast by Application (2025-2030)
